Show
Sort by
-
Dupilumab improves health-related quality of life in severe chronic rhinosinusitis with nasal polyps
-
- Miscellaneous
- open access
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
-
- Journal Article
- A1
- open access
Estimating clinically meaningful change of efficacy outcomes in inadequately controlled chronic rhinosinusitis with nasal polyposis
-
- Journal Article
- A1
- open access
Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma
-
Response to the correspondence : 'Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma'
-
Response to comment on : Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)
-
- Journal Article
- A1
- open access
Development of Sinonasal Outcome Test (SNOT-22) domains in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Olfactory outcomes with dupilumab in chronic rhinosinusitis with nasal polyps
-
- Journal Article
- A1
- open access
Asthma Daytime Symptom Diary (ADSD) and Asthma Nighttime Symptom Diary (ANSD) : measurement properties of novel patient-reported symptom measures
-
- Miscellaneous
- open access
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps